Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here

Pricing and Ordering Information
ClearState

Handheld Surgical Instruments Report: China
Report #CS2
10CH - January, 2014


China’s handheld surgical instruments market is fragmented but exhibiting rapid growth with the electrosurgical instrument segment leading the way.

The Chinese surgical instruments market is highly fragmented, covers numerous instrument types and has many domestic, regional and international manufacturers and suppliers. This report focuses on the two main segments: handheld instruments (scissors, cutters, blades, scalpels, graspers) and electrosurgical generators and accessories (radiofrequency, monopolar and bipolar devices as well as advanced energy devices). The characteristics and dynamics of the two segments are diverse with different players and behaviours.

Evolving demographics and ongoing government reform continually change the healthcare landscape in China. Improving standards of living, improved access to healthcare and the growing preference for minimally invasive surgeries are among the reasons driving the growth of the surgical equipment market. The total healthcare expenditure in China is expected to grow at a compound annual growth rate of more than 14.5% to exceed USD $900 billion by 2017. This growth is expected to drive the demand for surgical equipment, contributing to the relatively high expected growth of the overall handheld surgical instruments market.

The handheld surgical instruments market in China is currently estimated to be USD $203 million and is expected to grow at a CAGR of 8.8% to reach USD $309 million by 2018. The market is dominated by lower-value handheld supplies due to the large volumes of these instruments demanded. The electrosurgical segment is expected to have higher growth during this timeframe, primarily due to the increased precision and safety that the instruments provide. The current market for electrosurgery devices is estimated to be USD $88 million with an expected CAGR of 9.3%.

This report provides a breakdown of the market sizes, highlights the market potential of handheld and electrosurgical devices in China, and profiles the leading competitors in this market.

Ordering Information

Title

Report# Publication
Date
List Price

Handheld Surgical Instruments Report: China

CS210CH

January 2014

$5,950

Order Online:
Single User only (Please call for corporate subscription pricing)
    PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

1. INTRODUCTION

1.1 Report description

1.2 Research methodology

1.3 About the Author

1.4 Caveats and limitations

 

2. EXECUTIVE SUMMARY

 

3. DEFINITIONS

3.1 Surgical Instruments

3.2 Handheld surgical instruments

3.2.1 Scissors and Cutters

3.2.2 Graspers and Forceps

3.2.3 Scalpels

3.3 Electrosurgery Instruments

3.3.1 Electrosurgical technology

3.3.2 Electrosurgical devices

4. MARKET LANDSCAPE

4.1 Overview of Healthcare Infrastructure in China

4.2 Top line procedure volumes and growth, by key specialist areas

4.3 Regulatory Framework

 

5. SURGICAL INSTRUMENTS MARKET SIZE AND GROWTH

5.1 Overall surgical instruments market size and growth

5.2 Break-up of mechanical handheld devices

5.3 Electrosurgical devices market size and growth

5.4 Competitor landscape and market share

 

6. GROWTH DRIVERS AS MODERATORS

6.1 Market drivers

6.1.1 Rising investments in healthcare by government and private sector

6.1.2 Improving healthcare infrastructure

6.1.3 Increasing affluence and access to healthcare

6.1.4 Population demographics, changing lifestyles and evolving disease trends

6.2 Market barriers

6.2.1 Price competitive local competitors

6.2.2 Lack of trained surgeons

6.2.3 Gap in access to healthcare

 

7. COMPANY PROFILES

7.1 Covidien

7.2 Ethicon Endo-Surgery

7.3 BBraun

7.4 Olympus

7.5 ERBE Elektromedizin GmbH

7.6 Conmed

 

APPENDIX

a. Abbreviations

b. List of Exhibits

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.800.332.2181) or fax 1.908.748.1222.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home